Delivery Order SPE2DB22D3011-SPE2DB24FQ0GA
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,207.62, is for the supply of XYLOCAINE-MPF 1% VIAL 30ML, a medical product. The contract has an ultimate completion date of February 3, 2025 and was awarded on January 31, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of XYLOCAINE-MPF 1% VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA). The firm fixed price delivery order contract has a potential value of $1,042.89 and a period of performance through February 7, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is not associated with any set-aside designation. The company has a...
- This contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,965.70 firm-fixed-price Delivery Order contract is for the supply of XYLOCAINE-MPF 2% 100 MG/5 ML 5ML, a pharmaceutical product. The contract has an ultimate completion date of September 5, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting various defense and civilian agencies....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XYLOCAINE-MPF 1% VIAL 5ML, a local anesthetic medication. The contract is a Delivery Order with a Firm Fixed Price of $1,386.88 and an ultimate completion date of September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of XYLOCAINE-MPF 1% VIAL 30ML, a pharmaceutical product. The award, valued at $1,301.92, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,027.93, is for the delivery of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of July 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply XYLOCAINE-MPF 2% 100 MG/5 ML 5ML pharmaceuticals. The $1,742.00 delivery order has a completion date of January 11, 2024. Amerisourcebergen Drug Corp, as a prime contractor, provides a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities to support military treatment programs. The...
- This federal contract award, valued at $7,148.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for Xylocaine-MPF 2% (40 mg/2 mL vials) with a ceiling value of $1,253.12. This non-set-aside, firm fixed-price delivery order is expected to be completed by September 29, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the federal medical supply chain managed by the Defense...
- The Defense Logistics Agency awarded a $1,122 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562054906 XYLOCAINE-MPF 1% VIAL 5ML pharmaceutical products. The order is being fulfilled under an existing prime vendor contract vehicle to supply medical materiel to various Department of Defense customers. Amerisourcebergen will deliver the products from its facility in Conshohocken, Pennsylvania by September 6, 2023 to meet customer requirements, with no subcontractors...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FQ0GADelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract, valued at $1,288.53, is for the supply of XYLOCAINE-MPF 1% VIAL 30ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 3/29/24 |